AU2001274020A1 - Combination of active substances containing montirelin and compound having an opioid effect - Google Patents

Combination of active substances containing montirelin and compound having an opioid effect

Info

Publication number
AU2001274020A1
AU2001274020A1 AU2001274020A AU7402001A AU2001274020A1 AU 2001274020 A1 AU2001274020 A1 AU 2001274020A1 AU 2001274020 A AU2001274020 A AU 2001274020A AU 7402001 A AU7402001 A AU 7402001A AU 2001274020 A1 AU2001274020 A1 AU 2001274020A1
Authority
AU
Australia
Prior art keywords
montirelin
compound
combination
active substances
substances containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274020A
Other languages
English (en)
Inventor
Boris Chizh
Thomas Christoph
Babette-Yvonne Kogel
Achim Schuttler
Wolfgang Strassburger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kutzenberg & Wolff
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU2001274020A1 publication Critical patent/AU2001274020A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001274020A 2000-05-26 2001-05-10 Combination of active substances containing montirelin and compound having an opioid effect Abandoned AU2001274020A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10025947A DE10025947A1 (de) 2000-05-26 2000-05-26 Wirkstoffkombination enthaltend Montirelin und eine Verbindung mit opioider Wirksamkeit
DE10025947 2000-05-26
PCT/EP2001/005345 WO2001091733A2 (fr) 2000-05-26 2001-05-10 Combinaison de principes actifs contenant de la montireline et un compose a effet opioide

Publications (1)

Publication Number Publication Date
AU2001274020A1 true AU2001274020A1 (en) 2001-12-11

Family

ID=7643551

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274020A Abandoned AU2001274020A1 (en) 2000-05-26 2001-05-10 Combination of active substances containing montirelin and compound having an opioid effect

Country Status (5)

Country Link
AR (1) AR029096A1 (fr)
AU (1) AU2001274020A1 (fr)
DE (1) DE10025947A1 (fr)
PE (1) PE20011272A1 (fr)
WO (1) WO2001091733A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
EP2538928B1 (fr) * 2010-02-24 2017-05-03 Cima Labs Inc. Formulations à l'épreuve d'un usage abusif

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4426378A (en) * 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant

Also Published As

Publication number Publication date
AR029096A1 (es) 2003-06-04
DE10025947A1 (de) 2001-11-29
PE20011272A1 (es) 2002-01-26
WO2001091733A2 (fr) 2001-12-06
WO2001091733A3 (fr) 2002-04-04

Similar Documents

Publication Publication Date Title
AU2001274021A1 (en) Active substance combination containing an opioid having a fentanyl-type structure and ketamine
AU2002253619A1 (en) Heterocyclic compound and antitumor agent containing the same active ingredients
HK1045817B (zh) 含有活性組分的掩蔽結構顆粒
AU7419900A (en) Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines
AU2002338806A1 (en) Pharmaceutical combinations of pde-v inhibitors and other agents
AU2164101A (en) Fungicidal combinations of active substances
IL145475A0 (en) Compounds that inhibit impdh enzyme and pharmaceutical compositions containing the same
AU2001265008A1 (en) Caspase inhibitors and uses thereof
AU2001236457A1 (en) Compounds and compositions for delivering active agents
AU3114100A (en) Fabrication of electrodes and devices containing electrodes
GB0005839D0 (en) Storage and delivery of micro-organisms
AU2002328494A1 (en) Drugs containing chymase inhibitor and ACE inhibitor as the active ingredients
AU2001284985A1 (en) Compounds and compositions for delivering active agents
HUP0201334A3 (en) Hydrochloride of fused-heterocycle compound and pharmaceutical compositions containing the same
EP1419785A4 (fr) Medicaments contenant un inhibiteur de la chymase et un inhibiteur de l'ace comme principes actifs
AU2001241729A1 (en) Protected forms of pharmacologically active agents and uses therefor
AU2001234114A1 (en) Drugs containing combined active ingredients
AU2001233069A1 (en) Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
AU2001288277A1 (en) Compounds and compositions for delivering active agents
AU2001268131A1 (en) Stabilized compositions containing oxygen-labile active agents
AU2001292732A1 (en) Beta-lactam analogs and uses therefor
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001269188A1 (en) Solid fuel and fuel mixture containing same